Author:
Garcés-Ramírez Linda,Green Jennifer L.,Hiranita Takato,Kopajtic Theresa A.,Mereu Maddalena,Thomas Alexandra M.,Mesangeau Christophe,Narayanan Sanju,McCurdy Christopher R.,Katz Jonathan L.,Tanda Gianluigi
Funder
Intramural Research Program of the National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
NIDA
Reference51 articles.
1. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog;Martin;J Pharmacol Exp Ther,1976
2. Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog;Vaupel;Eur J Pharmacol,1983
3. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine;Gundlach;J Neurosci,1986
4. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF, 10:047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine;Largent;J Pharmacol Exp Ther,1986
5. A proposal for the classification of sigma binding sites;Quirion;Trends Pharmacol Sci,1992